DAVA
Endava plc
There isn't enough reported data to score DAVA yet.
MU
Micron Technology, Inc.
MU's fundamentals are strong and it looks cheap: trading at 11x earnings, about half its usual 22x. Analysts expect strong earnings growth.
DAVA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Under pressure |
DAVA's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
DAVA PE Valuation
DAVA has no meaningful PE right now: it lost money over the past year.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
DAVA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect DAVA's earnings to grow and its profitability to improve, with its revenue holding steady.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over DAVA on the outlook, with more favorable revenue expectations.
DAVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2026 | -$10.60 | -2818% |
| Q4 2025 | -$0.11 | -192% |
| Q3 2025 | $0.21 | +31% |
| Q2 2025 | $0.46 | +21% |
| Q1 2025 | $0.39 | -59% |
| Q4 2024 | $0.12 | -92% |
| Q3 2024 | $0.16 | -91% |
| Q2 2024 | $0.38 | -82% |
MU has the stronger earnings trend. Trailing diluted EPS is down 2,818% for DAVA versus MU up 879%.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU's earnings per share have climbed steadily: $74.33 over the past year, about 10 times what it earned the year before, and higher year over year for 10 quarters in a row.
DAVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $242.7M | -6.4% |
| Q4 2025 | $241.7M | -7.1% |
| Q3 2025 | $237M | -8.6% |
| Q2 2025 | $248.5M | -3.9% |
| Q1 2025 | $259.2M | +12% |
| Q4 2024 | $260.2M | +6.6% |
| Q3 2024 | $259.5M | +3.5% |
| Q2 2024 | $258.6M | +2.4% |
MU has the stronger quarterly revenue trend. Revenue is down 6.4% for DAVA versus up 379% for MU.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -3.4% | -12 points |
| Q4 2025 | -2.3% | -3.2 points |
| Q3 2025 | -1.6% | -4 points |
| Q2 2025 | 4.7% | +4 points |
| Q1 2025 | 8.4% | +9.5 points |
| Q4 2024 | 0.9% | -1.7 points |
| Q3 2024 | 2.4% | -6.2 points |
| Q2 2024 | 0.6% | -11 points |
DAVA's operating margin was −3.4% last quarter, down 12 points from the same quarter a year ago, near the bottom of its range since 2019.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU's revenue has grown year over year for 12 quarters in a row: $54.2B last quarter, up 379% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU's operating margin was 81% last quarter, up 48 points from the same quarter a year ago, near the top of its range since 2019.
DAVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$7.4M | -132% |
| Q4 2025 | $24.2M | -42% |
| Q3 2025 | $12.2M | +183% |
| Q2 2025 | -$5.4M | -$2.7M |
| Q1 2025 | $23M | +1044% |
| Q4 2024 | $42.1M | -6% |
| Q3 2024 | $4.3M | -79% |
| Q2 2024 | -$2.7M | -106% |
MU has the stronger cash trend. Its trailing FCF is up 3,213% versus its history, compared with DAVA at down 75%.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU generated $59B in free cash flow over the past year, more than ten times what it generated the year before.
DAVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -644K shares |
| 1 year | -12% | -7.2M shares |
| 3 years | -10% | -6M shares |
| 5 years | -8.7% | -5M shares |
| Available history | -5.4% | -3M shares |
DAVA has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | $3.4M |
| Q4 2025 | $2.4M |
| Q3 2025 | $30.5M |
| Q2 2025 | $62.5M |
| Q1 2025 | $23.7M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
DAVA spent $99M buying back its own shares over the past year, about four times what it spent the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
DAVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 2.9x | Moderate |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 1.8x | Healthy |
| Q3 2024 | 2.0x | Moderate |
| Q2 2024 | 1.8x | Healthy |
| Q1 2024 | -1.5x | Net Cash |
DAVA's net debt is about 3.5 years of its operating earnings (EBITDA), up from 1.8 years a year ago.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
DAVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.2 | Oversold |
| Stochastic | 5.2 | Oversold |
DAVA's weekly RSI is 29 (oversold) and its Stochastic is 5 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
DAVA PE vs Technology Sector
| Metric | DAVA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
DAVA has no meaningful PE right now: it lost money over the past year.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
DAVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.84 | 17% below |
| 20 week MA | $2.51 | 39% below |
| 50 week MA | $3.94 | 61% below |
| 100 week MA | $10.7 | 86% below |
| 200 week MA | $29.8 | 95% below |
DAVA is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over DAVA on trend strength, trading above more of its moving averages.
DAVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.7 | $77.3 | +59% |
| 2021 | $77.3 | $163.1 | +111% |
| 2022 | $163.1 | $74.8 | -54% |
| 2023 | $74.8 | $77.9 | +4.1% |
| 2024 | $77.9 | $30.5 | -61% |
| 2025 | $30.5 | $6.62 | -78% |
| 2026 YTD | $6.62 | $1.52 | -77% |
DAVA's yearly returns have swung widely, from +111% in 2021 to −78% in 2025. It's down 77% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over DAVA on returns for 2026, with the stronger performance.